ロード中...
Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced Cardiotoxicity
BACKGROUND: Doxorubicin (DOX) induces cardiotoxicity in part by activation of matrix metalloproteinases (MMPs). Sacubitril/valsartan (Sac/Val) exerts additive cardioprotective actions over renin-angiotensin-aldosterone inhibitors in preclinical models of myocardial infarction and in heart failure pa...
保存先:
| 出版年: | JACC CardioOncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7799406/ https://ncbi.nlm.nih.gov/pubmed/33437965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccao.2020.09.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|